Free Trial

Northwest & Ethical Investments L.P. Increases Stock Position in Xylem Inc. $XYL

Xylem logo with Business Services background

Key Points

  • Northwest & Ethical Investments L.P. increased its holdings of Xylem Inc. by 3.2% in the first quarter, owning 234,430 shares worth approximately $28 million.
  • Analysts exhibit a generally positive outlook for Xylem, with a consensus rating of "Moderate Buy" and a target price averaging $151.57, highlighting expectations for growth and stock performance.
  • Xylem recently announced a quarterly dividend of $0.40 per share, representing an annualized dividend yield of 1.1% and a payout ratio of 41.56%.
  • Looking to export and analyze Xylem data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Northwest & Ethical Investments L.P. increased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 3.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 234,430 shares of the industrial products company's stock after purchasing an additional 7,308 shares during the period. Northwest & Ethical Investments L.P. owned approximately 0.10% of Xylem worth $28,005,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Dynamic Advisor Solutions LLC acquired a new stake in Xylem during the 1st quarter worth approximately $694,000. Farther Finance Advisors LLC lifted its holdings in Xylem by 30.4% during the 1st quarter. Farther Finance Advisors LLC now owns 1,797 shares of the industrial products company's stock worth $215,000 after buying an additional 419 shares in the last quarter. NBC Securities Inc. acquired a new stake in Xylem during the 1st quarter worth approximately $72,000. GAMMA Investing LLC lifted its holdings in Xylem by 29.1% during the 1st quarter. GAMMA Investing LLC now owns 4,241 shares of the industrial products company's stock worth $507,000 after buying an additional 956 shares in the last quarter. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in Xylem by 19.4% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 27,215 shares of the industrial products company's stock worth $3,251,000 after buying an additional 4,429 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.

Wall Street Analysts Forecast Growth

XYL has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Stifel Nicolaus raised their price objective on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a report on Friday, August 1st. Citigroup restated a "buy" rating and issued a $152.00 price objective (up from $137.00) on shares of Xylem in a report on Monday, July 14th. JPMorgan Chase & Co. initiated coverage on shares of Xylem in a report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price objective on the stock. Finally, UBS Group raised their price objective on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Six research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Xylem currently has a consensus rating of "Moderate Buy" and a consensus target price of $151.57.

Get Our Latest Stock Analysis on XYL

Xylem Stock Up 0.6%

Shares of NYSE XYL traded up $0.87 during mid-day trading on Tuesday, reaching $141.72. The company had a trading volume of 1,177,045 shares, compared to its average volume of 1,151,543. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The firm has a 50 day simple moving average of $133.35 and a two-hundred day simple moving average of $126.12. The stock has a market cap of $34.50 billion, a P/E ratio of 36.81, a PEG ratio of 2.44 and a beta of 1.11. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $145.33.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. Xylem's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's payout ratio is presently 41.56%.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Strong Earnings? Market Says NVIDIA-Level Growth or Be Forgotten
Palantir’s Soaring Valuation—Justified or Overhyped?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines